The agreed settlement involves a payment of EUR 397,500 and a publication by name on the website of the Financial Services and Markets Authority (FSMA). This press release is not available in English. Please consult the French or Dutch site. Source: FSMA
ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTORITY, PUBLISHED IN APPLICATION OF ARTICLE 34, § 2, PARAGRAPH 3, OF THE LAW OF 2 AUGUST 2002 Trading in Tigenix, ISIN code BE0003864817 on Euronext Brussels will re-open on 01/06/2011 at 08:15am. Source: FSMA
ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTORITY, PUBLISHED IN APPLICATION OF ARTICLE 34, § 2, PARAGRAPH 3, OF THE LAW OF 2 AUGUST 2002 Trading in financial instrument Tigenix, ISIN code BE0003864817 on Euronext Brussels is suspended at request of the issuer from 08:15am on 31/05/2011 until the publication of a press release […]
ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTORITY, PUBLISHED IN APPLICATION OF ARTICLE 34, § 2, PARAGRAPH 3, OF THE LAW OF 2 AUGUST 2002 Trading in DEXIA and derivatives, ISIN code BE0003796134 on Euronext Brussels will re-open on 27/05/2011 at 01:40pm. Source: FSMA
ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTORITY, PUBLISHED IN APPLICATION OF ARTICLE 34, § 2, PARAGRAPH 3, OF THE LAW OF 2 AUGUST 2002 Trading in DEXIA and derivatives, ISIN code BE0003796134 on Euronext Brussels is suspended from 10:32 on 27/05/2011 until the publication of a press release. Source: FSMA
ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTORITY, PUBLISHED IN APPLICATION OF ARTICLE 34, § 2, PARAGRAPH 3, OF THE LAW OF 2 AUGUST 2002 Trading in MDXHealth, ISIN code BE0003844611 on Euronext Brussels will re-open on 06/04/2011 at 08:20am. Source: FSMA